stoxline Quote Chart Rank Option Currency Glossary
  
Acumen Pharmaceuticals, Inc. (ABOS)
2.7  0.05 (1.89%)    06-12 16:00
Open: 2.72
High: 2.745
Volume: 238,163
  
Pre. Close: 2.65
Low: 2.64
Market Cap: 162(M)
Technical analysis
2024-06-12 4:20:07 PM
Short term     
Mid term     
Targets 6-month :  3.91 1-year :  4.57
Resists First :  3.35 Second :  3.92
Pivot price 2.91
Supports First :  2.44 Second :  2.03
MAs MA(5) :  2.61 MA(20) :  3.12
MA(100) :  3.52 MA(250) :  4.15
MACD MACD :  -0.3 Signal :  -0.3
%K %D K(14,3) :  14.7 D(3) :  12.1
RSI RSI(14): 35
52-week High :  11.31 Low :  1.8
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ABOS ] has closed above bottom band by 34.0%. Bollinger Bands are 37.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.75 - 2.76 2.76 - 2.77
Low: 2.61 - 2.62 2.62 - 2.64
Close: 2.68 - 2.7 2.7 - 2.72
Company Description

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Headline News

Fri, 07 Jun 2024
Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? - Yahoo Lifestyle UK

Tue, 04 Jun 2024
Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? - Yahoo New Zealand News

Sat, 01 Jun 2024
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Down 12.0% in May - MarketBeat

Thu, 30 May 2024
Franklin Resources Inc. Has $12.90 Million Stake in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) - MarketBeat

Wed, 15 May 2024
Acumen Pharmaceuticals' (ABOS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Tue, 14 May 2024
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 60 (M)
Shares Float 32 (M)
Held by Insiders 11.2 (%)
Held by Institutions 77.9 (%)
Shares Short 816 (K)
Shares Short P.Month 1,050 (K)
Stock Financials
EPS -1.05
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.36
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -16.9 %
Return on Equity (ttm) -25.4 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.1
Qtrly Earnings Growth 0 %
Operating Cash Flow -51 (M)
Levered Free Cash Flow -35 (M)
Stock Valuations
PE Ratio -2.58
PEG Ratio 10.7
Price to Book value 0.61
Price to Sales 0
Price to Cash Flow -3.2
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android